ADAM9 and lip and oral cavity carcinoma: Consistently, among several salivary proteases, elevated ADAM9 levels are indeed considered a biomarker for OSCC screening and diagnosis [38], whereas an up-regulation of t-PA expression is not obviously found in oral cancer cells in comparison with adjacent non-malignant epithelial cells [39].